| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Altimmune, Inc. (ALT) has 16 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. ALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 420.3K | $1.28M | - | |
| Other | 150.0K | $456.0K | - | |
| Other | 100.1K | $304.4K | - | |
| Other | 96.0K | $291.8K | - | |
| Dir | 48.8K | $148.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Durso Jerome Benedict | President And CEO | Buy | 20,000 | $3.54 | $70,790.00 | +160.0% | - | - | |
| Mar 6, 2026 | Weaver Gregory L | Chief Financial Officer | Buy | 5,000 | $3.54 | $17,700.00 | +21.7% | - | - | |
| Jan 8, 2026 | Pisano Wayne | Director | Buy | 5,000 | $4.08 | $20,410.00 | +58.8% | -17.4% | - | |
| Jan 5, 2026 | Sohn Catherine A.55 | Director | Buy | 500 | $4.24 | $2,117.55 | +50.0% | -18.6% | - | |
| Dec 29, 2025 | Jorkasky Diane | Director | Buy | 527 | $3.80 | $2,002.60 | New | -21.7% | - | |
| Dec 23, 2025 | Gill John | Director | Buy | 12,500 | $4.10 | $51,250.00 | New | -14.0% | - | |
| Dec 22, 2025 | Durso Jerome Benedict | Director | Buy | 12,500 | $4.13 | $51,568.75 | New | -16.9% | - | |
| Mar 17, 2025 | Sohn Catherine A.55 | Director | Buy | 1,000 | $5.78 | $5,784.50 | New | +15.1% | -40.9% | |
| Mar 13, 2025 | Weaver Gregory L | Chief Financial Officer | Buy | 10,000 | $5.20 | $51,996.00 | New | +25.8% | -32.7% | |
| Aug 19, 2024 | Drutz David65 | Director | Sale+OE | 16,011 | $6.90 | $110,547.03 | -14.1% | -5.2% | -52.0% |